Laboratory medicine's practitioners across the European community include medical, scientifi c and pharmacy trained specialists whose contributions to health and healthcare is in the application of diagnostic tests for screening and early detection of disease, differential diagnosis, monitoring, management and treatment of patients, and their prognostic assessment. In submitting a revised common syllabus for post-graduate education and training across the 27 member states an expectation is set for harmonised, high quality, safe practice. In this regard an extended 'Core knowledge, skills and competencies' division embracing all laboratory medicine disciplines is described. For the fi rst time the syllabus identifi es the competencies required to meet clinical leadership demands for defi ning, directing and assuring the effi ciency and effectiveness of laboratory services as well as expectations in translating knowledge and skills into ability to practice. In a 'Specialist knowledge' division, the expectations from the individual disciplines of Clinical Chemistry/Immunology, Haematology/Blood Transfusion, Microbiology/ Virology, Genetics and In Vitro Fertilisation are described. Beyond providing a common platform of knowledge, skills and competency, the syllabus supports the aims of the European Commission in providing safeguards to increasing professional mobility across European borders at a time when demand for highly qualifi ed professionals is increasing and the labour force is declining. It continues to act as a guide for the formulation of national programmes supplemented by the needs of individual country priorities.
Introduction
It has been estimated that up to 70 % of all medical decisions are based on data and information provided by laboratory medicine (1, 2) . It is the clinical specialty that underpins modern medicine ' s understanding of health and disease. Its contributions include screening and early detection of disease, differential diagnosis, monitoring, management and treatment of patients, and their prognostic assessment. This contribution continues to grow through research and development, technological advances and the increasing knowledge and skills base of its practitioners across the 27 European Union (EU) member states. Central to extending that base is a syllabus for education and training that is fi t for purpose in meeting modern medicine ' s demands for better health and best care.
The European Communities Confederation of Clinical Chemistry ' s (EC4) syllabus for clinical chemistry and laboratory medicine was fi rst published in 1997 (3) . This is its fourth revision. The syllabus describes the level of knowledge and skills required from specialists, who have responsibility for patient care, but recognises that the scope of practice varies across the member states (4) , in part depending on whether:
the specialist is from a medical, scientifi c or pharmacy (a) background. Medical practitioners comprise about one third of such specialists, their key additional contribution being the provision of direct patient care; the specialisation is monovalent (typically clinical chem-(b) istry, the largest discipline) or polyvalent (to include one or more of haematology, blood transfusion, microbiology, virology, parasitology, immunology, genetics, reproductive medicine).
The overlap in scope, however, is considerable such that common elements in education and training can be identifi ed in a unifi ed syllabus. Since the last revision was published in 2005 (5) , much has changed in terms of the demands placed on the specialist and the service that he/she provides. In part these changes are predicated by individual member states ' priorities but, increasingly, common themes emerge in the provision of healthcare across the European Community. Changes include:
Greater clinical governance expectations for evidence-(a) based protocol-driven care which place new expectations for design of appropriate pathways involving diagnostic tests; Increasing demands for professionals to be registered (b) and/or professional practice to be regulated so that the public and patients are protected in the knowledge that safe care is provided by individuals whose competency is maintained through continuous professional development and/or re-validation; A shift from voluntary to mandatory accreditation of (c) services that expects standards to be met in areas, such as laboratory management and personnel, premises and environment, technology and information systems, preanalytical and post-analytical phases, audit, evaluation, quality assurance and its management (6, 7) ; Technological advances in areas, such as proteomics, (d) molecular diagnostics and mass spectrometry. These advances cross discipline-specifi c barriers, allowing enhanced diagnostic accuracy, but place new knowledge and skill demands on laboratory services; Increasing interest in exploitation of near patient testing (e) as a means of enhancing clinical, fi nancial and organisational outcomes; Increasing prioritisation to improving public health as a (f) means of reducing later hospital admissions and costly care.
A syllabus fi t for purpose
The changes in professional and clinical expectations are refl ected in a revised content and structure of the syllabus -' Core knowledge, skills and competencies ' describes common expectations across laboratory medicine followed by specialist knowledge relating to Clinical Chemistry/Immunology, Haematology/Blood Transfusion, Microbiology/Virology, Genetics and in vitro fertilisation. Amongst the most signifi cant revisions under core knowledge ' Laboratory Management and Quality Assurance ' refl ects enhanced expectations for direction, leadership, organisation, quality, education/training, safety, legal, ethical and governance considerations; ' Research and Development ' has been extensively revised and identifi es commitment to audit; enhanced roles in results interpretation and patient intervention are refl ected in a revised ' Case-related clinical evaluation of laboratory tests ' . The specialist knowledge sections have been retained for this revision.
Overarching the new structure is the identifi cation of competencies as measures of fi tness to practice and provide clinical leadership in defi ning a service, identifying the resources required to support effi ciency and effectiveness whilst meeting national medico-legal and regulatory requirements. The competencies identifi ed here complement those identifi ed by Beastall et al. (8) and Gurr et al. (9) as being appropriate for, respectively, ' consultant ' and ' specialist ' level practise. They are broken down to be associated with the individual sections. In identifying competencies the distinct contribution of the specialist in ensuring high quality, safe practice is underlined. They provide the standards of profi ciency that must be met, e.g., for registration and regulation purposes. They can also provide the cornerstone measures for individual appraisal and personal development.
Recognising professional qualifi cations
To date, the European Register of Specialists in Clinical Chemistry and Laboratory Medicine (10) has recognised over 2500 individuals across the EU as being able to demonstrate:
At least 9 years of undergraduate and post-graduate (a) study; A minimum of 5 years specialist training in an approved (b) laboratory to a level at least equivalent to that in the European syllabus;
Inclusion on a professional register in their home country; (c) Participation in continuous professional development (d) activities.
Since its inception in 1997, registrants have held the title European Specialist in Clinical Chemistry and Laboratory Medicine ( EurClinChem ). The Register is a key facilitator in disseminating high quality practice and extending recognition of the profession. The weight of its argument comes from the growing numbers of specialists wishing to join it, the quality of its argument from the standards it sets (11, 12) . Potentially the Register acts as a key inventory item for establishing a common mechanism for automatic recognition of professional qualifi cations across Europe for the two thirds of specialists with a pharmacy or science training background (13) . Currently only medically qualifi ed specialists enjoy the automatic recognition that allows professional mobility across European borders. Such mobility is important in supporting individual choice and encouraging a more equitable distribution of human resources and expertise across the EU at a time when demand for highly qualifi ed professionals is increasing whilst the labour force is declining (14, 15) . The identifi cation of competencies in the revised syllabus hence takes on additional signifi cance in allowing practitioners to demonstrate their ability to deliver common expectations for high quality, safe practice across European borders.
In 2007 EC4 merged with the Forum of European Societies of Clinical Chemistry and Laboratory Medicine (FESCC) to form the European Federation of Clinical Chemistry and Laboratory Medicine (EFCC) (16) . A key initiative in 2011 of the newly formed organisation has been to replace the 1997 EurClinChem title with the term Specialist in Laboratory Medicine. In unifying previous descriptors the new term provides a common theme to the profession as well as clarity to the general public. Its adoption also brings individual disciplines and their national societies together under a common umbrella of infl uence to enhance high quality practice across the EU. This paper is the report of a working group which has been endorsed by the Executive Board of EFCC after two rounds of consultation with national society representatives on the EC4 Register Commission who commented on manuscripts and contributed with examples of their national education and training programmes. The outcome is a framework that is capable of interpretation by governments and national societies in individual EU countries to help deliver a common approach to education and training. 
Competencies
Thorough knowledge of all aspects of clinical laboratory • sciences relevant to the discipline practiced. Broad knowledge of, and insight into, biochemical pro-• cesses in human health and disease on a general and patient-specifi c level.
II. Indications for laboratory medicine procedures
In the early detection of disease or disease susceptibility, 1.
screening, and in epidemiology. In disease related diagnosis. 2.
In organ related diagnosis. 3.
In monitoring vital functions and predicting disease 4.
outcome.
In treatment targeting, predicting and monitoring the 5.
response to therapy. Indications for subsequent specialised examinations. 6.
Indications for functional tests. 7.
Prognostic assessment. 8.
Competencies
Appreciation of developments in science and technology • and in the understanding of disease in order to ensure the appropriate use of laboratory investigations.
III. Infl uence of collection and storage of specimens
Place and time of sample collection, preservation, infl u-1.
ence of nutrition, drugs, posture, fasting state, etc. Choice and correct use of anticoagulants and transport 2.
media, order of draw, tourniquet effects. Care of the specimens, patient identifi cation, transport, 3.
storage, stability of analytes, infl uence of temperature, freezing/thawing.
Competencies
Recognition of pre-analytical factors that infl uence the • validity of the analytical process; Ability to deliver the pre-analytical requirements of a labo-• ratory medicine service. parasite and fungus identifi cation (including principal differential characteristics).
IV. Analytical principles and techniques

Competencies
Knowledge of, and insight into, the use of technology and • analytical techniques relevant to the fi eld of specialisation, an active appreciation of developments, and an attitude of innovation and creativity in their implemen tation.
V. Analytical evaluation of laboratory methods
Precision, accuracy, sensitivity, specifi city. 1.
Interference.
2.
Analytical and clinical ranges, limits of detection, carry over. 3.
Internal quality assurance and external quality assessment. 4.
Statistical comparison of methods. 5.
Defi nitive methods, reference methods, primary and sec-6. ondary calibrants, traceability. Laboratory and population data: sampling, reference values. 7.
Negative and positive predictive values of results; diag-8.
nostic sensitivity and specifi city, diagnostic accuracy; liklelihood ratios. Confi dence intervals. 9.
Competencies
Ability to determine the essential parameters required to • evaluate a laboratory method. Ability to conduct an evaluation using appropriate statisti-• cal tools, computer-aided spreadsheets and databases. Ability to determine the clinical signifi cance of the out-• come of a laboratory method evaluation.
VI. Clinical evaluation of laboratory methods
Reference intervals and biological variability. 1.
Genetic infl uences, environmental infl uences, age, sex, nutrition, season and time of day, infl uence of therapeutic agents.
Clinical sensitivity, specifi city and predictive value of ana-2.
lytical methods . Diagnostic strategies and analytical goals in the use of 3.
clinical chemistry tests.
Competencies
Ability to obtain, explore, and employ knowledge and • methods of investigation in the interests of health care and humankind. Ability to take responsibility for the data and information • produced, including knowledge of the infl uence of variation (biological as well as analytical) on interpretation of data.
VII. Case-related medical evaluation of laboratory tests
The specialist in laboratory medicine in a consultative role requires a working knowledge of the subject underlying the choice of tests and interpretation of results. 
X. Laboratory management and quality assurance
Depending on the working environment the consultant should be familiar with some or all aspects of the responsibilities listed below. Some may be led on an organisation-wide basis, some fall within the remit of the lead consultant, some may also be delegated.
Laboratory direction and leadership 1.
Specifying requirements. i.
Setting strategy and establishing policy. ii.
Formulating laboratory plans. iii.
Assessing resource requirements -staff, space, equipment . iv.
Analysing costings (effi ciency) and cost-benefi ts v.
(effectiveness). Laboratory organisation 2.
Design and utilisation of space and facilities. i.
Selection To know how to perform in situ hybridisation fl uo-• rescent technique: centromeric probe, chromosome painting probe, specifi c probe of a locus on metaphase or interphase.
To acquire the necessary knowledge to perform compar-• ative genomic hybridisation on microarrays .
To appreciate the validity criteria of molecular cytogene-• tics assays.
To be able to describe the analysis strategy of the underlisted abnormalities and to recognise their diagnostic, prognosis and/or therapeutic interest:
Chromosome number abnormalities . lowing pathological types and to recognise their diag
